JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
PUT
Union Pacific
UNP
$164B
| $2.63M | ﹤0.01% |
33,100
-177,200
| -84% | -$13.7M |
2014 Q3
6 quarters
|
|
|
MITT
2427
TPG Mortgage Investment Trust
MITT
$180M
| $2.63M | ﹤0.01% |
67,075
-1,025
| -2% | -$37.4K |
2015 Q4
1 quarter
|
|
2428
First Trust Multi Cap Value AlphaDEX Fund
FAB
$156M
| $2.63M | ﹤0.01% |
61,121
-19,157
| -24% | -$753K |
2013 Q2
11 quarters
|
|
2429
Constellium
CSTM
$3.46B
| $2.62M | ﹤0.01% |
504,971
+69,985
| +16% | +$402K |
2014 Q3
6 quarters
|
|
|
VMW
2430
CALL
DELISTED
VMware, Inc
VMW
| $2.62M | ﹤0.01% |
50,000
-32,000
| -39% | -$1.58M |
2014 Q3
6 quarters
|
|
2431
Larimar Therapeutics
LRMR
$289M
| $2.61M | ﹤0.01% |
32,607
-2,335
| -7% | -$184K |
2014 Q3
6 quarters
|
|
|
MYOK
2432
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.61M | ﹤0.01% |
+244,037
| New | +$2.22M |
2016 Q1
0 quarters
|
|
2433
Celldex Therapeutics
CLDX
$2.43B
| $2.61M | ﹤0.01% |
46,009
+22,404
| +95% | +$2.52M |
2013 Q2
11 quarters
|
|
2434
PUT
Teck Resources
TECK
$32.9B
| $2.6M | ﹤0.01% |
+342,000
| New | +$1.85M |
2016 Q1
0 quarters
|
|
|
HIBB
2435
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.6M | ﹤0.01% |
72,300
+15,600
| +28% | +$520K |
2015 Q4
1 quarter
|
|
2436
Enterprise Financial Services Corp
EFSC
$2.16B
| $2.59M | ﹤0.01% |
95,900
-2,900
| -3% | -$79.1K |
2013 Q2
11 quarters
|
|
|
INFI
2437
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.59M | ﹤0.01% |
492,050
-9,075
| -2% | -$55.5K |
2014 Q4
5 quarters
|
|
2438
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $2.57M | ﹤0.01% |
20,433
+16,437
| +411% | +$2.05M |
2013 Q2
11 quarters
|
|
2439
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $2.55M | ﹤0.01% |
46,480
+8,862
| +24% | +$479K |
2013 Q2
11 quarters
|
|
|
QTS
2440
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.55M | ﹤0.01% |
53,795
+13,959
| +35% | +$623K |
2015 Q1
4 quarters
|
|
|
MIME
2441
DELISTED
Mimecast Limited
MIME
| $2.55M | ﹤0.01% |
261,724
+33,155
| +15% | +$306K |
2015 Q4
1 quarter
|
|
|
BLUE
2442
DELISTED
bluebird bio
BLUE
| $2.54M | ﹤0.01% |
4,603
+302
| +7% | +$185K |
2014 Q3
6 quarters
|
|
|
RT
2443
DELISTED
Ruby Tuesday Georgia
RT
| $2.53M | ﹤0.01% |
470,025
+27,150
| +6% | +$142K |
2015 Q1
4 quarters
|
|
|
K
2444
CALL
DELISTED
Kellanova
K
| $2.53M | ﹤0.01% |
+35,145
| New | +$2.43M |
2016 Q1
0 quarters
|
|
|
WWAV
2445
DELISTED
The WhiteWave Foods Company
WWAV
| $2.53M | ﹤0.01% |
62,153
-110,171
| -64% | -$4.19M |
2013 Q2
11 quarters
|
|
2446
FIVE9
FIVN
$2.49B
| $2.52M | ﹤0.01% |
283,800
-191,915
| -40% | -$1.51M |
2015 Q2
3 quarters
|
|
2447
Washington Trust Bancorp
WASH
$729M
| $2.52M | ﹤0.01% |
67,605
-575
| -0.8% | -$21.5K |
2013 Q2
11 quarters
|
|
2448
Brown & Brown
BRO
$20.4B
| $2.52M | ﹤0.01% |
140,602
-6,566
| -4% | -$105K |
2013 Q2
11 quarters
|
|
|
FGP
2449
DELISTED
Ferrellgas Partners, L.P.
FGP
| $2.51M | ﹤0.01% |
144,055
-1,013,026
| -88% | -$16.9M |
2013 Q2
11 quarters
|
|
2450
Editas Medicine
EDIT
$419M
| $2.5M | ﹤0.01% |
+72,500
| New | +$1.91M |
2016 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.